Today's Daily Dose brings you news about FDA nod for GenMark Diagnostics' ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel; Akorn appointing a new CEO, and pipeline update of Proteostasis Therapeutics.
from RTT - Biotech http://bit.ly/2EALZom
via IFTTT
No comments:
Post a Comment